Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Front Pharmacol
.
2016 Nov 22:7:431.
doi: 10.3389/fphar.2016.00431.
eCollection 2016.
Author
Maurizio Renna
1
Affiliation
1
Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome Trust, Addenbrooke's Hospital, University of Cambridge Cambridge, UK.
PMID:
27920721
PMCID:
PMC5118441
DOI:
10.3389/fphar.2016.00431
No abstract available
Keywords:
cancer therapeutics; drug design; mTOR inhibitors; mTOR pathway; resistance mechanisms.
Publication types
Comment